Tibet AIM Pharm. Inc. (SHE:002826)
China flag China · Delayed Price · Currency is CNY
19.50
-0.02 (-0.10%)
Apr 30, 2026, 3:04 PM CST

Tibet AIM Pharm. Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
3,6523,4421,9012,2631,9432,094
Market Cap Growth
86.02%81.09%-16.02%16.48%-7.19%11.85%
Enterprise Value
3,0182,8911,5271,9811,7241,954
Last Close Price
19.5018.3810.3211.7810.0210.66
PE Ratio
38.1637.1841.39147.1044.0349.29
PS Ratio
5.455.412.923.392.272.89
PB Ratio
4.364.222.553.022.592.91
P/TBV Ratio
4.554.412.713.222.873.25
P/FCF Ratio
22.3529.8719.1413.8329.7824.83
P/OCF Ratio
21.2027.8217.0413.5628.3919.11
EV/Sales Ratio
4.504.542.342.972.012.69
EV/EBITDA Ratio
24.9924.5631.2840.3924.9829.95
EV/EBIT Ratio
29.5229.3256.0179.5337.2246.99
EV/FCF Ratio
18.4725.0915.3712.1026.4223.17
Debt / Equity Ratio
-0.010.030.020.07-
Debt / EBITDA Ratio
-0.100.470.220.73-
Debt / FCF Ratio
-0.100.230.070.77-
Net Debt / Equity Ratio
-0.76-0.64-0.54-0.50-0.36-0.25
Net Debt / EBITDA Ratio
-5.24-4.47-8.29-7.64-3.93-2.80
Net Debt / FCF Ratio
-3.88-4.57-4.07-2.29-4.16-2.17
Asset Turnover
0.640.660.700.690.930.84
Inventory Turnover
2.562.264.116.2312.1517.12
Quick Ratio
2.542.902.762.512.003.22
Current Ratio
2.783.223.012.862.193.65
Return on Equity (ROE)
11.69%11.93%6.35%2.10%6.27%6.18%
Return on Assets (ROA)
6.12%6.34%1.84%1.60%3.14%3.00%
Return on Invested Capital (ROIC)
33.04%25.62%5.99%3.89%7.07%6.82%
Return on Capital Employed (ROCE)
12.10%12.00%3.60%3.30%6.10%5.70%
Earnings Yield
2.56%2.69%2.42%0.68%2.27%2.03%
FCF Yield
4.47%3.35%5.23%7.23%3.36%4.03%
Dividend Yield
0.51%-0.97%0.26%1.00%0.94%
Payout Ratio
25.32%25.75%13.14%131.81%44.78%35.95%
Buyback Yield / Dilution
0.74%-0.79%4.48%-0.23%0.61%-3.37%
Total Shareholder Return
1.25%-0.79%5.45%0.03%1.61%-2.43%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.